News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
IARC has evaluated the carcinogenicity of talc and of acrylonitrile
Jul 6, 2024, 23:07

IARC has evaluated the carcinogenicity of talc and of acrylonitrile

“IARC has evaluated the carcinogenicity of talc and of acrylonitrile.
The outcome of the assessment has been published in a summary article in The Lancet Oncology and will be described in detail in Vol. 136 of the Monographs, to be published in 2025.
Read the IARC press release for more information here.”

IARC has evaluated the carcinogenicity of talc and of acrylonitrile

Source: IARC/LinkedIn     .

acrylonitrile cancer carcinogenicity IARC IARC - International Agency for Research OncoDaily Oncology talc The Lancet
Special Coverage
Blog
Oct 5, 2024, 10:39
Anna-Elina Rahikainen: Thank you IPOS for the opportunity to present
Blog
Oct 5, 2024, 09:50
Jashodeep Datta Named Principal Investigator for $2.5M NCI R37 MERIT Grant
Blog
Oct 5, 2024, 09:30
Medicaid expansion increased use of adjuvant therapy for NSCLC
Insight
Oct 5, 2024, 09:27
Patricia P. Falconer: Patients residing in rural communities have more barriers to care and a higher risk of financial toxicity
Blog
Oct 5, 2024, 09:26
Emily Holthuis: Expanding Partnerships with Patients and Carers in the EORTC
Blog
Oct 5, 2024, 09:24
Andreas Brandl: Prophylactic use of HIPEC in T4 colorectal cancer at ESSO43
Blog
Oct 5, 2024, 09:22
Doublet Immunotherapy Options for Unresectable Hepatocellular Carcinoma
Insight
Oct 5, 2024, 09:20
DESTINY-Breast06 is the first study to investigate a HER2-directed therapy in patients with HER2-ultralow tumors - ASCO
Blog
Oct 5, 2024, 09:17
Mark Lawler: Economist Impact taking money from Big Tobacco while running heath conferences
Blog
Oct 5, 2024, 09:16
Jame Abraham: Shlomo Koyfman appointed as the Director of Precision Oncology Program at Cleveland Clinic
Blog
Oct 5, 2024, 09:15
Zainab Shinkafi-Bagudu: Fostering Global health equity through my work
Blog
Oct 5, 2024, 09:11
Owkin is entering a new partnership with AstraZeneca to develop a gBRCA pre-screening solution in breast cancer directly from digitised pathology slides